EUR 2.48
(0.0%)
Breakdown | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | 227.29 Thousand | 192.16 Thousand | 228.12 Thousand | 135.82 Thousand | 173.35 Thousand |
Net Income | 9.05 Million | 17.16 Million | 1.71 Million | 1.61 Million | 515.4 Thousand | 23.5 Thousand |
Depreciation & Amortization | - | 113.64 Thousand | 96.08 Thousand | 114.06 Thousand | 135.82 Thousand | 173.35 Thousand |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | - | - | - | - |
Other non-cash items | -9.05 Million | -17.16 Million | -1.71 Million | -1.61 Million | -515.4 Thousand | -23.5 Thousand |
Investing Cash Flow | - | - | - | - | - | - |
Investments in PPE | - | - | - | - | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - | - |
Debt repayment | - | - | - | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | - | - | - | - |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | - | - | - | - | - | - |
Cash at beginning of period | - | - | - | - | - | - |
Cash at end of period | - | 227.29 Thousand | 192.16 Thousand | 228.12 Thousand | 135.82 Thousand | 173.35 Thousand |
Capital Expenditure | - | - | - | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | - | 227.29 Thousand | 192.16 Thousand | 228.12 Thousand | 135.82 Thousand | 173.35 Thousand |
Free Cash Flow | - | 227.29 Thousand | 192.16 Thousand | 228.12 Thousand | 135.82 Thousand | 173.35 Thousand |
Breakdown | 2023 Q2 | 2022 Q4 | 2022 FY | 2022 Q2 | 2021 FY | 2021 Q4 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | - | - | 9.05 Million | 11.56 Thousand | 17.16 Million | 10.07 Thousand |
Depreciation & Amortization | - | - | - | 63.92 Thousand | 113.64 Thousand | 61.93 Thousand |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | - | - | - | - |
Other non-cash items | - | - | -9.05 Million | -11.56 Thousand | -17.16 Million | -10.07 Thousand |
Investing Cash Flow | - | - | - | - | - | - |
Investments in PPE | - | - | - | - | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - | - |
Debt repayment | - | - | - | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | - | - | - | - |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | - | - | - | - | - | - |
Cash at beginning of period | - | - | - | - | - | - |
Cash at end of period | - | - | - | 127.85 Thousand | 227.29 Thousand | 123.86 Thousand |
Capital Expenditure | - | - | - | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | - | - | - | 127.85 Thousand | 227.29 Thousand | 123.86 Thousand |
Free Cash Flow | - | - | - | 127.85 Thousand | 227.29 Thousand | 123.86 Thousand |
CMPS
GENESYS
0QNM
WEIGF
ALAQU
HGRVF